Dr. Megan Moreno (top) and Dr. Annika Hofstetter (bottom)
Seattle Children’s has the honor of having over 100 doctors and researchers slated to present at the 2015 Pediatric Academic Societies (PAS) Annual Meeting. This is the largest international meeting focused on children’s health research and clinical implications.
On the Pulse is highlighting two Seattle Children’s researchers who will be presenting their exciting new research: Dr. Megan Moreno and Dr. Annika Hofstetter.
Using media to understand mechanisms of behavior change
Alyssa Bowen appears to be an average 15-year-old on the outside, but inside, her body is fighting a civil war. Her immune system is hyperactive, creating antibodies to attack her own blood cells, platelets, white blood cells and tissues. Despite the extensive efforts of doctors and nurses, they have not been able to offer Alyssa an exact diagnosis.
Alyssa has been coming to Seattle Children’s Hospital from a very young age. She has had many hospitalizations and a variety medications and treatments to help her manage her puzzling condition and the pain associated with it. Read full post »
Dr. Bryan King worries that each time the media includes the MMR vaccine and autism in the same sentence, even if reporting the lack of association, the false idea of a linkage between the two is perpetuated.
A significant body of validated research over the last 15 years has found no link between the measles-mumps-rubella (MMR) vaccine and autism spectrum disorders, yet the false myth that this vaccine may cause or intensify the disorder continues to circulate among some families of children with autism. As a result, some parents delay or forgo the life-saving MMR vaccine for their children.
On May 1, Dr. Tom Hansen will step down as Seattle Children’s CEO after 10 years of service. During his leadership, Hansen was known as a visionary with big ideas – big ideas that helped us become one of the best children’s hospitals in the world while getting us closer than ever to achieving our goal of eliminating pediatric disease.
In May, Hansen will pass the CEO baton to Dr. Jeff Sperring, but he has no plans to stop innovating on behalf of Seattle Children’s. He will be returning to his research roots full time, continuing to pursue his passion of helping improve outcomes for premature infants as an investigator at Seattle Children’s Research Institute. In his research, he will focus on the development of low-cost ventilators for premature infants born in low- and middle-income countries. Read full post »
Dr. Mike Jensen, director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute, will be a keynote speaker at the 4th International Conference on Immunotherapy in Pediatric Oncology.
“We expect to bring together hundreds of national and international oncology and immunology professionals with the goal of providing opportunities for scientific exchange, collaboration, problem-solving and mentoring,” said Dr. Mike Jensen, director of the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute. “The conference will provide a venue to present new data and explore emerging concepts in an effort to bring immune-based therapies to more children with pediatric cancer.” Read full post »
About 70,000 young people ages 15 to 39 are diagnosed with cancer each year in the U.S., and cancer is leading cause of death from disease in this age group. While cancer survival continues to improve for children and older adults, outcomes have greatly lagged for teens and young adults.
Dr. Daniel Rubens, Seattle Children’s Hospital Anesthesiologist
Two Seattle Children’s Hospital doctors have teamed up as an unlikely pair working to find an answer to one of the most elusive pediatric mysteries: what causes Sudden Infant Death Syndrome (SIDS)? One is a pediatric anesthesiologist, Dr. Daniel Rubens, the other is the Director of the Center for Integrative Brain Research, Nino Ramirez, Ph.D. With help from Travis Allen, a nurse anesthetist at Seattle Children’s, the two researchers are hoping to provide answers to families who have lost babies to SIDS and help medical professionals better understand the risk factors.
On the Pulse caught up with Rubens recently to answer a few of the most common questions about SIDS and his research.
This story was originally featured in Seattle Children’s Hospital 2014 Academic Annual Report. The report provides a look into the top clinical and research accomplishments that took place at Seattle Children’s in 2014.
Appendicitis is one of the most common reasons children need surgery, yet diagnosis and treatment approaches vary greatly among hospitals and caregivers and are not always based on best practices.
The Washington State Hospital Association (WSHA) chose Drs. Adam Goldin and Daniel Ledbetter as part of a statewide team to draft standardized diagnostic and clinical care guidelines for appendicitis in 2014. The goals for the new guidelines are to reduce radiation exposure, provide clear guidance for giving antibiotics and outline other evidence-based practices to improve care for hundreds of children throughout Washington state each year. Read full post »
Dr. Mark Stein is leading several ongoing research studies to improve ADHD treatments.
Seattle Children’s Program to Evaluate and Enhance Attention, Regulation and Learning (PEARL) clinic aims to treat children with attention deficit hyperactivity disorder (ADHD) and associated problems using the newest and most effective treatments available. To determine which of those treatments is most appropriate for each patient, Dr. Mark Stein, director of the PEARL Clinic and investigator in Seattle Children’s Research Institute’s Center for Child Health, Behavior and Development, is leading several ongoing research studies that are currently enrolling patients. Read full post »
Dr. Sihoun Hahn led a collaborative research study which helped a 10-year-old girl walk for the first time in her life.
A collaborative research study led by Dr. Sihoun Hahn, director of the Biochemical Genetics program at Seattle Children’s and an investigator within Seattle Children Research Institute’s Center for Developmental Therapeutics, has changed the lives of children around the world and helped a 10-year-old girl walk for the first time.
Research answers a parent’s prayer
Bokyung Kim, a 10-year-old living in Korea, spent most of her life confined to a wheelchair. Doctors suspected that she suffered from muscular dystrophy, but were unable to diagnose her condition. Bokyung’s parents prayed that their daughter would walk one day. So when they had the opportunity to enroll Bokyung in a collaborative research study between Seattle Children’s Research Institute, University of Washington School of Medicine and Seoul National University College of Medicine in Korea, her parents were eager to participate.
“This family never lost hope for their child,” Hahn said. “And neither did we.” Read full post »
Seattle Children’s provides healthcare for the special needs of children regardless of race, color, creed, national origin, religion, sex (gender), sexual orientation or disability. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.